Extensive LDL-cholesterol lowering by PCSK9 inhibitor on the risk of venous thrombosis
This editorial refers to ‘Role of PCSK9 inhibitor in venous thromoembolism: current evidece and unmet needs’, by Zuin et al. doi: 10.1093/ehjcvp/pvae076.
This editorial refers to ‘Role of PCSK9 inhibitor in venous thromoembolism: current evidece and unmet needs’, by Zuin et al. doi: 10.1093/ehjcvp/pvae076.
XT.COM is a secure cryptocurrency exchange for trading bitcoin, ethereum, and altcoins with deep liquidity and low fees. We are paving the way for global…
There has been a transformation in clinical care and outcomes for patients with cardiovascular disease in recent times. This has largely been enabled by th
Check out our registration prices. Renaissance Polat İstanbul Hotel, Yeşilyurt, Sahil Yolu Cd. No:2, 34149 Bakırköy/İstanbul. Congress participation certificates will be given as e-certificates to…
Learn the latest research results during these Late-Breaking Sessions.
Contemporary randomized clinical trials (RCTs) in heart failure (HF) now consistently inform clinical outcomes such as cardiovascular death or HF hospitalizations. Given the size of…
An official journal of the European Society of Cardiology. Publishes high quality material, both clinical and scientific, on all aspects of Cardiovascular Medicine – including…
This patient-level meta-analysis of a variety of randomized clinical trials examines the association between mean Kansas City Cardiomyopathy Questionnaire treatment effects and the absolute differences…
Desde el Congreso LAHRS 2024 en Cartagena, Colombia, los renombrados cardiólogos Dr. Armando Pérez Silva y Dr. Parik Sharma comparten sus ideas sobre el futu…
Cardiologist and researcher at Mass General / Broad Institute / Harvard Med. Preventive cardiology, women’s health, genomics.
Dr Spencer Nadolsky of the “Docs Who Lift” podcast joins Dave to recap obesity week, and to deep dive into Dave’s ongoing struggle with obesity…